Stem definition | Drug id | CAS RN |
---|---|---|
atropine derivatives | 223 | 80-50-2 |
None
Property | Value | Reference |
---|---|---|
BA (Bioavailability) | 17.50 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Date | Agency | Company | Orphan |
---|---|---|---|
Nov. 23, 1962 | FDA | ENDO PHARMS |
None
None
None
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:48876 | muscarinic antagonists |
CHEBI has role | CHEBI:49201 | anti-ulcer drugs |
CHEBI has role | CHEBI:50370 | parasympatholytics |
MeSH PA | D018678 | Cholinergic Agents |
MeSH PA | D018680 | Cholinergic Antagonists |
MeSH PA | D018727 | Muscarinic Antagonists |
MeSH PA | D018377 | Neurotransmitter Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Peptic ulcer | indication | 13200003 | DOID:750 |
Gastric ulcer | indication | 397825006 | DOID:10808 |
Irritable bowel syndrome | off-label use | 10743008 | DOID:9778 |
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Muscarinic acetylcholine receptor M1 | GPCR | ANTAGONIST | DRUGBANK | CHEMBL | |||||
Muscarinic acetylcholine receptor M3 | GPCR | ANTAGONIST | DRUGBANK | CHEMBL |
ID | Source |
---|---|
4018547 | VUID |
N0000179041 | NUI |
17945 | RXNORM |
C0051923 | UMLSCUI |
CHEBI:2739 | CHEBI |
CHEMBL1578 | ChEMBL_ID |
657201 | PUBCHEM_CID |
DB00517 | DRUGBANK_ID |
C100237 | MESH_SUPPLEMENTAL_RECORD_UI |
367554003 | SNOMEDCT_US |
913 | INN_ID |
4018547 | VANDF |
62M960DHIL | UNII |
001748 | NDDF |
None